| CEO: | Sean M. Smith |
| CFO: | Alexander John Abrey |
| Non-Executive Chairman: | Lykele van der Broek |
| Non-Executive Dir: | Robin James Scott Cridland, Derek McAllan |
| Address: | 67C Innovation Drive, Milton Park, Abingdon, Oxfordshire, England, United Kingdom, OX14 4RQ |
| Website: | http://www.edenresearch.com/ |
| Sector: | Pharma and Biotech(LSE) |
| Index: | FTSE AIM All-Share |
| ISIN: | GB0001646941 |
| Currency | UK Pounds |
| Share Price | 3.45p |
| Change Today | 0.15p |
| % Change | 4.55 % |
| 52 Week High | 4.80 |
| 52 Week Low | 2.10 |
| Volume | 551,131 |
| Shares Issued | 803.36m |
| Market Cap | £27.72m |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 14:33 | 530,000 @ 3.37p |
| 13:23 | 143 @ 3.40p |
| 11:17 | 143 @ 3.20p |
| 11:17 | 1,360 @ 3.40p |
| 11:17 | 50 @ 3.40p |
| CFO | Alexander John Abrey |
| CEO | Sean M. Smith |
You are here: research